Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR‐383‐5p/vesicle‐associated membrane protein‐2 axis
Abstract We aimed to explore the function and underlying mechanism of highly upregulated in liver cancer (HULC; an long noncoding RNAs) in hepatocellular carcinoma (HCC) and chemosensitivity of oxaliplatin (Oxa). The expression of HULC, miR‐383‐5p, and vesicle‐associated membrane protein‐2 (VAMP2) w...
Main Authors: | Peng Li, Yuwei Li, Lieting Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.815 |
Similar Items
-
MicroRNA-383: A tumor suppressor miRNA in human cancer
by: Abdollah Jafarzadeh, et al.
Published: (2022-10-01) -
LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis
by: Yi Hu, et al.
Published: (2019-11-01) -
Prognostic and predictive roles of microRNA-383 in colorectal cancer
by: Alavieh Fateh, et al.
Published: (2016-08-01) -
LncRNA Zfas1 boosts cell apoptosis and autophagy in myocardial injury induced by hypoxia via miR-383-5p/ATG10 axis
by: Miaomiao Liu, et al.
Published: (2024-02-01) -
Long noncoding RNA HULC contributes to paclitaxel resistance in ovarian cancer via miR-137/ITGB8 axis
by: Huang Bo, et al.
Published: (2021-07-01)